BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 19671794)

  • 21. Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?
    Shoenfeld Y; Meroni PL; Toubi E
    Curr Opin Rheumatol; 2009 Sep; 21(5):495-500. PubMed ID: 19593144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.
    Sanmarco M; Gayet S; Alessi MC; Audrain M; de Maistre E; Gris JC; de Groot PG; Hachulla E; Harlé JR; Sié P; Boffa MC
    Thromb Haemost; 2007 Jun; 97(6):949-54. PubMed ID: 17549297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future.
    Mehdi AA; Uthman I; Khamashta M
    Eur J Clin Invest; 2010 May; 40(5):451-64. PubMed ID: 20345380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel insights into pathogenesis, diagnosis and treatment of antiphospholipid syndrome.
    Wijetilleka S; Scoble T; Khamashta M
    Curr Opin Rheumatol; 2012 Sep; 24(5):473-81. PubMed ID: 22585233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. European Working Party on systemic lupus erythematosus and European Forum on Antiphospholipid Antibodies: two networks promoting European research on autoimmunity.
    Cervera R; Tincani A
    Lupus; 2009 Sep; 18(10):863-8. PubMed ID: 19671783
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiphospholipid antibodies and migraine: a retrospective study of 428 patients with inflammatory connective tissue diseases.
    Tănăsescu R; Nicolau A; Caraiola S; Ticmeanu M; Cojocaru IM; Frăsineanu A; Ionescu R; Hristea A; Ene A; Anghel D; Tănăsescu R; Băicuş C
    Rom J Intern Med; 2007; 45(4):355-63. PubMed ID: 18767411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The future of antiphospholipid antibody testing.
    de Groot PG; Urbanus RT
    Semin Thromb Hemost; 2012 Jun; 38(4):412-20. PubMed ID: 22618531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiphospholipid syndrome in systemic lupus erythematosus: is the whole greater than the sum of its parts?
    Laskin CA; Clark CA; Spitzer KA
    Rheum Dis Clin North Am; 2005 May; 31(2):255-72, vi. PubMed ID: 15922145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
    Vlachoyiannopoulos PG; Toya SP; Katsifis G; Zintzaras E; Tzioufas AG; Moutsopoulos HM
    J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Networking in Europe for special centres of excellence for autoimmune diseases.
    Vasconcelos C; Cervera R
    Lupus; 2009 Sep; 18(10):930-2. PubMed ID: 19671795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
    Asherson RA; Cervera R; Merrill JT; Erkan D
    Semin Thromb Hemost; 2008 Apr; 34(3):256-66. PubMed ID: 18720305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac manifestations in antiphospholipid syndrome.
    Soltész P; Szekanecz Z; Kiss E; Shoenfeld Y
    Autoimmun Rev; 2007 Jun; 6(6):379-86. PubMed ID: 17537384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing antiphospholipid antibodies and antiphospholipid syndrome in children.
    Kamat AV; D'Cruz DP; Hunt BJ
    Haematologica; 2006 Dec; 91(12):1674-80. PubMed ID: 17145604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
    Alijotas-Reig J; Casellas-Caro M; Ferrer-Oliveras R; Llurba-Olive E; Hermosilla E; Vilardell-Tarres M; Cabero-Roura L
    Am J Reprod Immunol; 2008 Sep; 60(3):229-37. PubMed ID: 18782284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome.
    Devreese K; Hoylaerts MF
    Eur J Haematol; 2009 Jul; 83(1):1-16. PubMed ID: 19226362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Apheresis in antiphospholipid syndrome (APS)].
    De Silvestro G; Tison T; Marson P
    G Ital Nefrol; 2012; 29 Suppl 54():S78-83. PubMed ID: 22388836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: a retrospective cohort-control study.
    Sugiura-Ogasawara M; Ozaki Y; Nakanishi T; Sato T; Suzumori N; Kumagai K
    Am J Reprod Immunol; 2008 Mar; 59(3):235-41. PubMed ID: 18275516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment.
    Tincani A; Bazzani C; Zingarelli S; Lojacono A
    Semin Thromb Hemost; 2008 Apr; 34(3):267-73. PubMed ID: 18720306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular manifestations in antiphospholipid syndrome.
    Suvajac G; Stojanovich L; Milenkovich S
    Autoimmun Rev; 2007 Jun; 6(6):409-14. PubMed ID: 17537387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.